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Skeletal health in primary 
hyperparathyroidism: role of 
kidney function
Walker et al., J Clin Endocrinol Metab 2012; 97: 1501–1507; doi:10.1210/
jc.2011-3072
There is a paucity of data as to the effects of chronic kidney disease 
(CKD) on the skeleton in patients with primary hyperparathy-
roidism (PHPT). Moreover, it is unclear whether parathyroidec-
tomy is beneficial or potentially harmful in patients with both 
PHPT and CKD. Walker et al. addressed this issue in a retro-
spective analysis, based on a previously described PHPT cohort 
recruited from 1984 to 1991. They studied 138 women and men 
who had an estimated glomerular filtration rate (eGFR) either 
above 60 ml/min per 1.73 m2 (CKD stages 1–2) or below 60 ml/
min per 1.73 m2 (mainly CKD stage 3a). They assessed bone min-
eral density (BMD) by dual-energy X-ray absorptiometry (DXA); 
quantitative histomorphometric indices from transiliac bone biop-
sies; and biochemical markers of mineral metabolism. They found 
no difference in serum or urinary calcium or ‘intact’ parathyroid 
hormone (iPTH) level, but serum calcitriol levels were lower and 
phosphate levels higher in patients with CKD. BMD did not differ 
at any site between groups. However, histomorphometric analy-
sis done in 30 of the 138 patients revealed a 45% greater eroded 
surface in those with CKD (Figure). Eroded surface correlated 
negatively with eGFR and serum phosphate and positively with 
serum calcium but not with iPTH, alkaline phosphatase, vitamin 
D metabolites, or urinary calcium excretion. Although there was 
no decrease in bone formation in those with CKD, there was a 
positive association between eGFR and osteoid surface, suggesting 
lower bone formation in those with the worst kidney function. The 
failure to observe lower BMD in those with CKD may be explained 
by the fact that most patients had stage 3a CKD. It also suggests 
that lower BMD as measured by DXA may become evident only 
in PHPT patients with more impaired kidney function.
Thus, patients with PHPT and mild kidney dysfunction have 
higher serum phosphate and lower serum calcitriol levels and 
altered bone remodeling compared with those without CKD. 
This observation should motivate additional studies aimed to 
assess the effect of parathyroidectomy on bone health and kidney 
function in subjects with PHPT and CKD.
Tilman B. Drüeke
Association of blood pressure  
with the start of renal replacement 
therapy in elderly compared 
with young patients receiving 
predialysis care
De Goeij et al., Am J Hypertens advance online publication, 19 July 2012, 
doi:10.1038/ajh.2012.100
Renal replacement therapy is not only an expensive treatment, but 
also one with a reduced quality of life, as many of the symptoms 
of chronic kidney disease (CKD) are not alleviated by initiation of 
dialysis. Therefore, most coordinated national health-care policies 
are centered on screening programs for high-risk groups, with 
early detection of CKD coupled with interventions designed to 
reduce progression. Hypertension has consistently been shown to 
be the major risk factor for progression of underlying kidney dis-
ease, and, until recently, strict blood pressure control has been the 
mantra of kidney doctors. However, this approach has been ques-
tioned by trials in type 2 diabetics, which reported that patients 
randomized to low blood pressure targets (systolic blood pressure 
110 mm Hg) fared worse than those randomized to allow higher 
targets (130 mm Hg). As the expansion in CKD is predominantly 
in older patients in more affluent societies, the Dutch PREPARE-1 
study group compared the effects of blood pressure control on 
progression of CKD in younger and older patients. As expected, 
there was a direct correlation between higher blood pressure 
and deterioration of kidney function in the younger age group, 
whereas for the older patient, there was no increased deteriora-
tion of kidney function with systolic hypertension of 160–179 
mm Hg compared with 140–159 mm Hg, and deterioration of 
kidney function was observed only with systolic blood pressure of 
≥180 mm Hg. Elderly patients with diastolic blood pressure lower 
than 70 mm Hg or with increased diastolic pressure of ≥100 mm 
Hg had a greater risk of progressing to require renal replacement 
therapy than elderly patients with diastolic pressure of 80–89 mm 
Hg, independent of systolic pressure.
The PREPARE-1 study results question current treatment 
paradigms, both in terms of the optimal blood pressure targets 
to minimize progression of CKD for different age groups, and 
in terms of the relative importance of systolic compared with 
diastolic blood pressure targets.
Andrew Davenport
Association between eroded bone surface (by bone 
histomorphometry) and eGFR (by MDRD) in patients with PHPT. 
MDRD, the Modification of Diet in Renal Disease equation.
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FAN1 mutations cause 
karyomegalic interstitial nephritis, 
linking chronic kidney failure to 
defective DNA damage repair
Zhou et al., Nat Genet 2012; 44: 910–915; doi:10.1038/ng.2347
Karyomegalic interstitial nephritis (KIN) is a rare progressive 
renal failure disorder with an autosomal recessive mode of inher-
itance. KIN is char acterized by degeneration of renal tubules and 
interstitial fibrosis, which is indistinguishable from that observed 
in nephronophthisis (NPHP). The only feature that distinguishes 
KIN from NPHP is the presence of karyomegaly, an increase in 
the nuclear size of tissue cells (Figure). Zhou and colleagues per-
formed exome sequencing and identified mutations in FAN1 as 
a cause of KIN. FAN1 is considered to be an effector of the Fan-
coni’s anemia path way, a DNA damage response (DDR) signaling 
pathway involved in the repair of DNA interstrand cross-link 
(ICL) damage. People with Fanconi’s anemia are characterized 
by developmental abnormalities, bone marrow failure, and pre-
disposition to cancer. However, while FAN1-deficient cells from 
people with KIN show hypersensitivity to ICL-inducing agents, 
FAN1 is not a typical susceptibility gene for Fanconi’s anemia. 
No FAN1 mutations have been detected in people with Fanconi’s 
anemia. The authors examined FAN1 mutant cells from people 
with KIN for genome instability and observed chromatid breaks 
and radial chromosomes on metaphase spreads, which is consis-
tent with a role for FAN1 in genome maintenance and DDR. Sur-
vival of FAN1 mutant cell lines from affected people was severely 
compromised after exposure to ICL-inducing agents. Comple-
mentation of the FAN1 defect in fibroblasts from people with 
KIN by transduction with wild-type FAN1 restored the abnormal 
phenotype. The authors also performed knock down of fan1 
in zebrafish and found development of KIN-like phenotypes. 
Finally, the authors examined human kidney transplant biopsy 
samples using gH2AX as a marker of DNA damage and found 
correlation of the extent of kidney damage and DNA lesions.
Cells sustain DNA damage from exogenous sources as well as 
from their own metabolism, which produces oxidative stress. Fol-
lowing filtration of blood, the kidney is also exposed to high lev-
els of toxic agents, which may induce DNA damage. The gradual 
accumulation of damage to the genome of the kidney cells will 
lead to incomplete DNA replication, causing polyploidization 
or karyomegaly, and eventual loss of kidney function in KIN.
Masaomi Nangaku
Effector T cells, as well as Tregs, 
may inhibit immune responses
Corse and Allison, J Immunol 2012; 189: 1123–1127; doi:10.4049/
jimmunol.1200695
Understanding the immunological basis of how the body controls 
the effector T cell response is important for the rational design of 
immunosuppressive regimes. The molecule cytotoxic T-lympho-
cyte antigen 4 (CTLA-4), a derivative of which, belatacept, has 
been approved recently for renal transplantation, is well known 
as a negative regulator of T cell responses. CTLA-4 competes with 
CD28 for B7 ligands, which are necessary for full immune activa-
tion. The precise mechanisms by which CTLA-4 inhibits T cell pro-
liferation are still unclear. Until recently, the immuno suppressive 
effect of CTLA-4 was thought to be mediated predominantly by 
Foxp3+ regulatory T cells (Tregs). Corse and Allison, along with 
Wang et al.1 in a companion piece, in the Journal of Immunol-
ogy, challenge this immunological concept. Using antigen-specific 
Foxp3– effector T cells in a normal immune environment, Corse 
and Allison show that cell-extrinsic suppression of T cell responses 
by CTLA-4 is not limited to Tregs but is also a property of the 
effector T cell compartment. With the use of adoptive transfer of 
CTLA-4-expressing effector T cells into CTLA-4-deficient recipi-
ent mice, Treg-independent suppression of proliferative responses 
was shown. Demonstrating that CTLA-4 expressed on effector 
T cells plays an important role in inhibiting immune responses 
raises the possibility that crossreacting effector T cells may exert a 
broader influence over polyclonal T cell responses, which contrib-
ute to allograft rejection and also antitumor responses.
Tregs themselves may be more potent negative regulators of 
immune responses because of greater expression of CTLA-4 on 
their cell surface.
This paper and its companion piece challenge the current para-
digm concerning the cellular mechanism of action of CTLA-4 in 
immune responses and the notion that dampening of immune 
responses is purely Treg dependent. They should prompt a 
reexamination of the effector T cell compartment in transplan-
tation and nephritis models.
P. Toby Coates
1J Immunol 2012; 189: 1118–1122.
Renal histology in people with KIN. Renal histology of people with KIN 
due to FAN1 mutation shows cystic dilation of renal tubules (asterisks) 
and widespread fibrosis (blue-gray coloring in Masson’s trichrome 
staining) associated with the characteristic karyomegaly (white 
arrowheads) in tubules.
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